Histone 3.3 participates in a self-sustaining cascade of apoptosis that contributes to the progression of chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 6, 2013, Pages 673-683

  Barrero, Carlos A ^a   Perez Leal, Oscar ^a   Aksoy, Mark ^a   Moncada, Camilo ^a   Ji, Rong ^a   Lopez, Yolanda ^a   Mallilankaraman, Karthik ^a   Madesh, Muniswamy ^a   Criner, Gerard J ^a   Kelsen, Steven G ^a   Merali, Salim ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylation; Chronic obstructive pulmonary disease; Cytotoxicity; Histone H3.3; Proteomics

Indexed keywords

GLUCOCORTICOID; HISTONE H3; PROTEASOME; PROTEOME;

APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CELL STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; MAJOR CLINICAL STUDY; MITOCHONDRION; PRIORITY JOURNAL; SMOKING; UBIQUITINATION;

ACETYLATION; APOPTOSIS; DISEASE PROGRESSION; HISTONES; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84884614312     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201302-0342OC     Document Type: Article

References (51)

1. Maclay JD, Rabinovich RA, MacNee W. Update in chronic obstructive pulmonary disease 2008. Am J Respir Crit Care Med 2009;179:533-541.
2. Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:524-526.
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2013;380:2095-2128.
4. Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:938-943.
5. NHLBI. Morbidity and mortality: 2009 chart book on cardiovascular, lung and blood diseases. Bethesda, MD: NIH Heart, Lung and Blood Institute-National Institutes of Health; 2009.
6. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 2009;15:303-307.
7. Postma DS, Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:434-439.
8. Salazar LM, Herrera AM. Fibrotic response of tissue remodeling in COPD. Lung 2011;189:101-109.
9. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:258-266; discussion 290-251.
10. Rajendrasozhan S, Yao H, Rahman I. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 2009;6:291-297.
11. Lamond AI, Earnshaw WC. Structure and function in the nucleus. Science 1998;280:547-553.
12. Voigt P, Reinberg D. Histone tails: ideal motifs for probing epigenetics through chemical biology approaches. Chem Bio Chem 2011;12:236-252.
13. Wood C, Snijders A, Williamson J, Reynolds C, Baldwin J, Dickman M. Post-translational modifications of the linker histone variants and their association with cell mechanisms. FEBS J 2009;276:3685-3697.
14. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatinbinding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 2007;14:1025-1040.
15. Barnes PJ. Histone deacetylase-2 and airway disease. Ther Adv Respir Dis 2009;3:235-243.
16. Barnes PJ. Role of hdac2 in the pathophysiology of COPD. Annu Rev Physiol 2009;71:451-464.
17. Barnes PJ. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:693-696.
18. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med 2009;15:1318-1321.
19. Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F, Wang SS, Brohi K, Kipar A, Yu W, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med 2013;187:160-169.
20. Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F. High mobility group protein b1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 2011;17:807-815.
21. Barrero CA, Kelsen SG, Aksoy M, Ji R, Merali S. Extracellular histones in the COPD lung are cytotoxic [abstract]. Am J Respir Crit Care Med 2011;183:A3018.
22. Szulakowski P, Crowther AJ, Jimenez LA, Donaldson K, Mayer R, Leonard TB, MacNee W, Drost EM. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:41-50.
23. Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, Shah V, Celli B, Brody JS. Gene expression profiling of human lung tissue from smokers with severe emphysema. Am J Respir Cell Mol Biol 2004;31:601-610.
24. Tilley AE, Harvey BG, Heguy A, Hackett NR, Wang R, O'Connor TP, Crystal RG. Down-regulation of the notch pathway in human airway epithelium in association with smoking and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179:457-466.
25. Malhotra D, Thimmulappa R, Vij N, Navas-Acien A, Sussan T, Merali S, Zhang L, Kelsen SG, Myers A, Wise R, et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 2009;180:1196-1207.
26. Varghese S, Gupta D, Baran T, Jiemjit A, Gore SD, Casero RA Jr, Woster PM. Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors. J Med Chem 2005;48:6350-6365.
27. Ford PA, Durham AL, Russell RE, Gordon F, Adcock IM, Barnes PJ. Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. Chest 2010;137:1338-1344.
28. Inamochi Y, Mochizuki K, Osaki A, Ishii T, Nakayama T, Goda T. Histone h3 methylation at lysine 4 on the slc2a5 gene in intestinal caco-2 cells is involved in slc2a5 expression. Biochem Biophys Res Commun 2010;392:16-21.
29. Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are mediators of death through tlr2 and tlr4 in mouse fatal liver injury. J Immunol 2011;187:2626-2631.
30. Cascone A, Bruelle C, Lindholm D, Bernardi P, Eriksson O. Destabilization of the outer and inner mitochondrial membranes by core and linker histones. PLoS ONE 2012;7:e35357.
31. Gamberucci A, Fulceri R, Marcolongo P, Pralong WF, Benedetti A. Histones and basic polypeptides activate Ca21/cation influx in various cell types. Biochem J 1998;331:623-630.
32. Kleine TJ, Lewis PN, Lewis SA. Histone-induced damage of a mammalian epithelium: the role of protein and membrane structure. Am J Physiol 1997;273:C1925-C1936.
33. Hung CC, Ichimura T, Stevens JL, Bonventre JV. Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by erk1/2 activation. J Biol Chem 2003;278:29317-29326.
34. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem 2005;74:739-789.
35. Zhang K, Kaufman RJ. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 2006;66:S102-S109.
36. Adcock IM, Tsaprouni L, Bhavsar P, Ito K. Epigenetic regulation of airway inflammation. Curr Opin Immunol 2007;19:694-700.
37. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165-1185.
38. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004;172:6692-6700.
39. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31:1334-1356.
40. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, Lohmeyer J, Preissner KT. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE 2012;7:e32366.
41. Ito K, Charron CE, Adcock IM. Impact of protein acetylation in inflammatory lung diseases. Pharmacol Ther 2007;116:249-265.
42. Buchwald M, Kramer OH, Heinzel T. HDACI-targets beyond chromatin. Cancer Lett 2009;280:160-167.
43. Arendt CS, Hochstrasser M. Eukaryotic 20s proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly. EMBO J 1999;18:3575-3585.
44. Szenker E, Ray-Gallet D, Almouzni G. The double face of the histone variant h3.3. Cell Res 2011;21:421-434.
45. Ray-Gallet D, Almouzni G. Nucleosome dynamics and histone variants. Essays Biochem 2010;48:75-87.
46. Jager R, Bertrand MJ, Gorman AM, Vandenabeele P, Samali A. The unfolded protein response at the crossroads of cellular life and death during endoplasmic reticulum stress. Biol Cell 2012;104:259-270.
47. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Natl Rev 2007;8:519-529.
48. Faitova J, Krekac D, Hrstka R, Vojtesek B. Endoplasmic reticulum stress and apoptosis. Cell Mol Biol Lett 2006;11:488-505.
49. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006;7:880-885.
50. Cho HY, Reddy SP, Debiase A, Yamamoto M, Kleeberger SR. Gene expression profiling of nrf2-mediated protection against oxidative injury. Free Radic Biol Med 2005;38:325-343.
51. Cullinan SB, Diehl JA. Perk-dependent activation of nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem 2004;279:20108-20117.